TYR115 IS THE KEY RESIDUE FOR DETERMINING AGONIST SELECTIVITY IN THE V1A VASOPRESSIN RECEPTOR

被引:158
作者
CHINI, B
MOUILLAC, B
ALA, Y
BALESTRE, MN
TRUMPPKALLMEYER, S
HOFLACK, J
ELANDS, J
HIBERT, M
MANNING, M
JARD, S
BARBERIS, C
机构
[1] INSERM,U401,F-34094 MONTPELLIER 05,FRANCE
[2] MARION MERRELL DOW RES INST,F-67080 STRASBOURG 05,FRANCE
[3] MED COLL OHIO,DEPT BIOCHEM,TOLEDO,OH 43699
关键词
AGONIST SELECTIVITY; DDAVP; MOLECULAR MODELING; RECEPTOR MUTAGENESIS; VASOPRESSIN RECEPTOR;
D O I
10.1002/j.1460-2075.1995.tb07211.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Using a three-dimensional model of G protein-coupled receptors (GPCR), we have previously succeeded in docking the neurohypophysial hormone arginine-vasopressin (AVP) into the V1a receptor, According to this model, the hormone is completely embedded in the transmembrane part of the receptor. Only the side chain of the Arg residue at position 8 projects outside the transmembrane core of the receptor and possibly interacts with a Tyr residue located in the first extracellular loop at position 115. Residue 8 varies in the two natural neurohypophysial hormones, AVP and oxytocin (OT); similarly, different residues are present at position 115 in the different members of the AVP/OT receptor family. Here we show that Arg8 is crucial for high affinity binding of AVP to the rat V1a receptor. Moreover, when Tyr115 is replaced by an Asp and a Phe, the amino acids naturally occurring in the V2 and in the OT receptor subtypes, the agonist selectivity of the V1a receptor switches accordingly, Our results indicate that the interaction between peptide residue 8 and the receptor residue at position 115 is not only crucial for agonist high affinity binding but also for receptor selectivity.
引用
收藏
页码:2176 / 2182
页数:7
相关论文
共 39 条
  • [21] CLONING AND CHARACTERIZATION OF A VASOPRESSIN V2 RECEPTOR AND POSSIBLE LINK TO NEPHROGENIC DIABETES-INSIPIDUS
    LOLAIT, SJ
    OCARROLL, AM
    MCBRIDE, OW
    KONIG, M
    MOREL, A
    BROWNSTEIN, MJ
    [J]. NATURE, 1992, 357 (6376) : 336 - 339
  • [22] STRUCTURE, FUNCTION, AND PHYLOGENY OF [ARG(8)]VASOTOCIN RECEPTORS FROM TELEOST FISH AND TOAD
    MAHLMANN, S
    MEYERHOF, W
    HAUSMANN, H
    HEIERHORST, J
    SCHONROCK, C
    ZWIERS, H
    LEDERIS, K
    RICHTER, D
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) : 1342 - 1345
  • [23] DESIGN, SYNTHESIS AND SOME USES OF RECEPTOR-SPECIFIC AGONISTS AND ANTAGONISTS OF VASOPRESSIN AND OXYTOCIN
    MANNING, M
    SAWYER, WH
    [J]. JOURNAL OF RECEPTOR RESEARCH, 1993, 13 (1-4): : 195 - 214
  • [24] MANNING M, 1992, INT J PEPT PROT RES, V40, P261
  • [25] MANNUCCI PM, 1977, LANCET, V1, P869
  • [26] MOLECULAR-CLONING AND EXPRESSION OF A RAT VIA ARGININE VASOPRESSIN RECEPTOR
    MOREL, A
    OCARROLL, AM
    BROWNSTEIN, MJ
    LOLAIT, SJ
    [J]. NATURE, 1992, 356 (6369) : 523 - 526
  • [27] MUTAGENESIS OF THE BETA-2-ADRENERGIC RECEPTOR - HOW STRUCTURE ELUCIDATES FUNCTION
    OSTROWSKI, J
    KJELSBERG, MA
    CARON, MG
    LEFKOWITZ, RJ
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1992, 32 : 167 - 183
  • [28] ROY C, 1975, J BIOL CHEM, V250, P3149
  • [29] SAVARESE TM, 1992, BIOCHEM J, V283, P1
  • [30] PROJECTION STRUCTURE OF RHODOPSIN
    SCHERTLER, GFX
    VILLA, C
    HENDERSON, R
    [J]. NATURE, 1993, 362 (6422) : 770 - 772